BiomX (PHGE) Earnings Date & Reports

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PHGE is expected to report earnings to fall 233.29% to -9 cents per share on November 13

Q3'24

Est.

$-0.09

Q2'24

Beat

by $0.16

Q1'24

Beat

by $0.35

Q4'23

Missed

by $0.42

Q3'23

Missed

by $0.03

The last earnings report on August 15 showed earnings per share of 7 cents, beating the estimate of -9 cents. With 21.65K shares outstanding, the current market capitalization sits at 13.36M.

View a ticker or compare two or three

Compare

PHGE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PHGE
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in developing bacteriophage-based therapies for the treatment and prevention of diseases stemming from dysbiosis of the microbiome

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

22 Einstein Street

Phone

+972 723942377

Employees

Web

https://www.biomx.com